Lincbiotech is a biotechnology startup based in Spain, established in 2017. The company specializes in developing technological solutions for medical image processing and analysis, serving as clinical decision-support systems for neurological diseases. Additionally, they focus on creating pharmacological solutions for the treatment of neurovascular diseases, such as strokes (ACV).
Lincbiotech is a spin-off of the Fundación Ramón Domínguez (FRD) and Conexiona, and it is dedicated to the development and commercialization of healthcare solutions aimed at the diagnosis, prevention, control, treatment, or relief of neurological diseases.
As of now, there is no publicly available information about the last investment received or the investors involved in the latest funding round.
Given its focus on cutting-edge medical technologies and its potential to address critical healthcare challenges, Lincbiotech presents an intriguing opportunity for investors looking to support innovative solutions in the biotechnology and pharmaceutical sectors.